Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
10 | 6011200 | 3 prime UTR variant | T/A | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 10 | 6011605 | 3 prime UTR variant | C/T | snv | 0.42 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 10 | 6013641 | intron variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.040 | 10 | 6019462 | frameshift variant | -/T | delins |
|
Immune System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 10 | 6021356 | intron variant | C/T | snv | 0.18 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 10 | 6021564 | missense variant | C/T | snv |
|
Immune System Diseases | 0.800 | 0 | |||||||||||
|
1.000 | 0.040 | 10 | 6024310 | stop gained | G/A | snv |
|
Immune System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 10 | 6025837 | missense variant | A/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 1994 | 1994 | |||||||
|
1.000 | 0.040 | 10 | 6025968 | missense variant | T/G | snv |
|
Immune System Diseases | 0.800 | 0 | |||||||||||
|
1.000 | 0.080 | 10 | 6025978 | missense variant | C/T | snv | 4.0E-06 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 10 | 6027930 | intron variant | C/A;T | snv |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
10 | 6030130 | intron variant | G/C | snv | 7.8E-03 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
10 | 6032488 | intron variant | G/A;C;T | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
1.000 | 0.040 | 10 | 6037072 | intron variant | G/C;T | snv |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.040 | 10 | 6039267 | intron variant | C/A | snv | 0.13 |
|
Digestive System Diseases | 0.800 | 1.000 | 2 | 2012 | 2015 | |||||||
|
1.000 | 0.040 | 10 | 6039267 | intron variant | C/A | snv | 0.13 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 10 | 6042690 | intron variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 10 | 6042690 | intron variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 10 | 6042690 | intron variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.160 | 10 | 6045332 | intron variant | G/T | snv | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.160 | 10 | 6045332 | intron variant | G/T | snv | 0.18 |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 10 | 6045831 | intron variant | G/A | snv | 0.28 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 10 | 6045831 | intron variant | G/A | snv | 0.28 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 10 | 6046736 | intron variant | A/G | snv | 0.51 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 10 | 6046736 | intron variant | A/G | snv | 0.51 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 |